Central Institutes and Interdisciplinary Centers
Central Institutes and Facilities of Faculty and Universitätsklinikum Erlangen
- provision of counseling and support to members of the Faculty of Medicine and staff of the Universitätsklinikum Erlangen for the conception, planning, conduct, and analysis of clinical studies, taking into account the relevant legal and regulatory requirements;
- support to the Universitätsklinikum Erlangen for fulfilling the rights and duties of the sponsor in clinical studies;
- administration of the insurance for participants in clinical studies;
- administration of the clinical studies database of the Faculty of Medicine;
- organization of educational events on all aspects of clinical
Since its inception, CCS Erlangen participated in about 350 clinical research projects of members of the Faculty of Medicine and staff of the Universitätsklinikum Erlangen. These comprise several multinational clinical studies in Europe and the USA as well as three projects involving the first administration to humans of novel medicinal products (first-in-man trials).
CCS Erlangen divides into the areas of study management and clinical monitoring, quality management, and pharmacovigilance.
The center organizes further education and training courses on topics in oncology and coordinates research projects. In addition, the CCC ER-EMN runs a free tumor consultancy service for patients and their relatives.
Nationwide, there are currently only 13 institutions as leading centers for cancer research and treatment, sponsored by German Cancer Aid.
The CCC ER-EMN was founded in December 2007 as the Erlangen University Cancer Center by members of staff at the Universitätsklinikum Erlangen and the Faculty of Medicine at the FAU. In January 2013, a cooperation agreement with Bamberg Hospital (Sozialstiftung Bamberg) and Bayreuth Hospital (Klinikum Bayreuth, Ltd.) was established. All three sites have oncological centers certified in accordance with the German Cancer Society (DKG) criteria.
Under the aegis of the CCC ER-EMN, there is a total of 13 certified organ cancer centers and 25 interdisciplinary tumor conferences in three oncological centers which are responsible for optimized patient care and multidisciplinary development of clinical pathways according to the most up-to-date standards.
- The development and application of targeted immunotherapies
- The establishment of new diagnostic procedures for disease detection and therapy monitoring
- The use of advanced digital health technologies
By combining these three synergistic fields of activity, DZI aims to enable individually targeted immunotherapy for cancer patients and patients with chronic inflammatory diseases.
The Center is a research-oriented animal facility that provides for customers a modern infrastructure and specific-pathogen-free conditions for preclinical animal experiments. The center offers various research related services, e.g. import of transgenic mouse strains via embryo transfer as well as veterinary advice and supervision for surgical or toxicological studies on large or small animals. Already as early as the time of project application, the team of the PETZ provides competent references in all areas of the application processes and related questions regarding experimental strategy.
With its infrastructure, the PETZ supports effective and optimized science and enables translational medical research in a controlled, standardized environment most appropriate for each of the species. Our center represents a professional and reliable partner on the way from the scientific idea and the consecutive ways ultimately resulting in benefits for the human patients.
The interdisciplinary centers facilitate the initiation of research projects beyond faculties and institutions.
The partners Siemens Healthineers, UK Erlangen, FAU, and Medical Valley EMN have joined forces in the cooperation network d.hip to implement outstanding research projects in the field of digitization of the health sector.
The EFC promotes collaborative research between its members and operates the core unit “Bioanalytics“ as well as several basic technical facilities. The EFC represents its members vis-à-vis third parties, coordinates interdisciplinary fund-raising activities and serves as a platform for cooperation with partners from the pharmaceutical and food industries. The interdisciplinary training of post-graduates is accomplished by the associated Emil-Fischer-Graduate School (EFS). At the end of 2014, the EFC was evaluated positively by the University and was granted increased support.
The ECI focuses on the analysis of the pathogenesis of infections in order to improve the prevention, diagnosis, and therapy of infectious diseases in the long run. Accordingly, the ECI aims at providing a close scientific interaction between medical doctors in the clinics (e.g. specialists for infectious diseases, dermatology, hematology, and oncology) as well as micro- biologists, virologists, infectious disease immunologists, pathologists, clinical pharmacologists, pharmaceutical, organic and inorganic chemists, and bioengineers. The necessity for an interdisciplinary and interfaculty cooperation and for combining the diverse scientific strength and know-how in the area of infection research becomes particularly apparent whenever novel anti-infectives, vaccines, or therapeutics for the treatment of immunopathological processes during chronic infections are to be developed. The broad spectrum of expertise of the ECI members in medicine and science will serve to open up new fields of research, such as the design and analysis of redox-active metal compounds for the therapy of infections and chronic inflammatory processes.
Moreover, the ISI is also a platform in which other medical centers and the public can get familiar with the latest developments regarding research and application of state-of-the-art medical imaging techniques. Aside from the acquisition of scientific findings, medical professionals and decision-makers working in public health all over the world will learn about quality improvement and opportunities to minimize costs by employing novel technologies. Within the eight years since its establishment, roughly 20,000 people from all over the world have visited the ISI Erlangen, among them numerous leaders of medical centers as well as representatives of public healthcare systems and politicians.
In the scientific areas medical imaging, pattern recognition, and preventive medicine, there was already scientific excellence in the Faculties of Medicine and Engineering. Embedded in the main research focus “Medical Technology” of the FAU, the IZPI should help to enforce and to improve the scientific excellence in these topics. The most important purpose of IZPI is the development of novel diagnostic methods in the area of preventive medicine. The goal is to develop new technologies for early detection of risk factors or symptoms of diseases.
Thus, the areas of interest of IZPI are
- development of novel technologies and
- improvement of well-established technologies by optimizing image acquisition, analysis, and medical
The analysis of medical images and data comprises all processes which lead to a medical interpretation or a transformation of the medical image in a symbolic description. To extract relevant risk factors from a given medical image, there is the necessity to develop an effective model of the disease. The model will allow elute relevant information from a given image.
Within the Nürnberg Metropolitan Region, the IZPH bundles all relevant stakeholders of the health care industry, i.e. medical professionals (doctors, hospitals trusts, outpatient sectors), the different statutory health and care insurance providers, health technology providers (global operating companies like Siemens Healthcare and pharmaceutical manufacturers), as well as patients and their family members.
Neuroscience at the Faculty comprises the molecular analysis of subcellular processes as well as clinically oriented research in the fields of diagnosis, therapy, or healthy services. Thus, the development of innovative approaches for translational medicine is an essential goal of ICN.
Since 2007 Medical Valley EMN e. V. operates as a uniting cluster management organization. It currently has more than 200 members from industrial, science, healthcare, network, and political sectors. The key tasks of cluster management are the development, coordination, and marketing of the cluster.
The aim of the Ludwig Demling Center is to clinically translate innovative translational research approaches into molecular imaging procedures and thereby create improved diagnostic and therapeutic algorithms for the lasting benefit of the patient.
covered in the center include aspects of inflammation-, tumor-, kidney-, heart-, and circulation research.
A central approach of the TRC is a highly efficient and flexible use of laboratory space. The research modules have a uniform floor plan. All laboratory areas are linked to a central middle zone which harbors multiuser equipment in order to ensure easy access and efficient utilization of advanced technologies. Several core units complement the infrastructure and provide a broad array of specialized methodologies. These include a central
isotope area that for example enables to generate markers used for innovative imaging techniques, a biobank for sample storage, processing, and analysis of blood and urine of patients, and a cutting edge unit for immune monitoring of patients. All research areas are connected with an open structure to facilitate intense interaction. To this end, a central communication area was created for all personnel.